MiMedx Group News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.02.18	Wolf Popper LLP Announces Investigation on Behalf of Investors in MiMedx Group, Inc. (PR Newswire)
20.02.18	Block & Leviton LLP Investigates MiMedx Group, Inc. (MDXG) Following Internal Investigation Over Accounting Practices (PR Newswire)
20.02.18	MiMedx Postpones Release of its Fourth Quarter and Fiscal Year 2017 Financial Results (PR Newswire)
25.01.18	MiMedx Adds New Materials To Its Website Exposing Misinformation Disseminated Through Short Sellers (PR Newswire)
24.01.18	Covisum Provides New Resources to Help Financial Advisors Navigate the Tax Cuts and Jobs Act (PR Newswire)
17.01.18	MiMedx Announces the Enrollment of the First Patients in the Phase 3 Clinical Trial of AmnioFix® Injectable for Achilles Tendonitis (PR Newswire)
17.01.18	EIGR Disappoints, EXEL's CELESTIAL Excels, JUNO In CELG's Crosshairs? (RTTNews)
16.01.18	MiMedx Announces First Patients Have Been Enrolled In The Phase 3 Clinical Trial Of AmnioFix® Injectable In Patients With Recalcitrant Plantar Fasciitis Pain (PR Newswire)
13.01.18	Mimedx To Host Shareholder Call On January 18, 2018 To Update Progress On Multiple Clinical Studies And Status Of Patent Portfolio (PR Newswire)
08.01.18	CELG Makes Blockbuster Purchase, MDXG, NBIX On Watch, Busy Year Ahead For ALNY (RTTNews)
07.01.18	MiMedx Releases Preliminary 2017 Revenue of $324.5 Million representing a 32% increase over 2016 (PR Newswire)
06.01.18	MiMedx Provides Update On Illegal Short Selling Activities Against The Company (PR Newswire)
20.12.17	4WD Supacentre Announces Launch of Brand-New Range of Adventure Kings Portable Ice Boxes (PR Newswire)
15.12.17	MiMedx Adds New Materials To Its Website Exposing Misinformation Disseminated Through Short Sellers (PR Newswire)
13.12.17	MiMedx Forecasts 2018 Revenue To Be In The Range Of $383 Million To $387 Million (PR Newswire)
12.12.17	MiMedx Announces Release Of 2018 Guidance And Shareholder Conference Call (PR Newswire)
06.12.17	Two Independent Poster Abstracts Highlighting The Clinical Efficacy of MiMedx Allografts are Recognized at The 2017 Desert Foot Conference (PR Newswire)
30.11.17	MiMedx Issues Shareholder Letter Detailing The Illegal Short Selling The Company Is Experiencing (PR Newswire)
30.11.17	MiMedx Announces Expectation To Exceed Top End of Fourth Quarter Revenue Guidance Of $88 Million (PR Newswire)
21.11.17	MiMedx to Present at the 29th Annual Piper Jaffray Healthcare Conference (PR Newswire)
21.11.17	MiMedx Provides Update On Its Reimbursement Coverage (PR Newswire)
20.11.17	MiMedx Adds New Materials To Its Website Exposing Misinformation Disseminated Through Short Sellers (PR Newswire)
17.11.17	MiMedx Market Leadership Well Positioned In Light Of FDA New Guidance Document (PR Newswire)
14.11.17	MiMedx Adds New Materials To Its Website Exposing Misinformation Disseminated Through Short Sellers (PR Newswire)
08.11.17	MiMedx To Webcast Its Investor's Day Conference on November 30, 2017 (PR Newswire)
08.11.17	MiMedx to Present at Jefferies 2017 London Healthcare Conference (PR Newswire)
02.11.17	MiMedx To Present At The Canaccord\|Genuity Medical Technology And Diagnostics Forum (PR Newswire)
30.10.17	MiMedx Group Investor Reminder and Update: Hagens Berman Reminds MiMedx Group Investors of Investigation into Possible Securities Law Violations Related to Report Questioning MiMedx's Accounting... (PR Newswire)
30.10.17	MiMedx CEO Replies to Fraudulent Information About The Company (PR Newswire)
27.10.17	MiMedx Exposes Content of a Short Seller Website Dedicated to Posting Defamatory and False Information About The Company (PR Newswire)
26.10.17	MiMedx Announces Record Results For Third Quarter Of 2017 And Raises Full Year Revenue Guidance (PR Newswire)
24.10.17	MiMedx Adds New Materials To Its Website Exposing Misinformation Disseminated Through Short Seller Attacks (PR Newswire)
18.10.17	New Clinical Evidence And A Landmark VLU Study To Be Presented At SAWC Fall Meeting (PR Newswire)
17.10.17	MiMedx Warns Of Fake Emails (PR Newswire)
17.10.17	MiMedx Notified By FDA That It Can Proceed With Phase 2B Investigational New Drug Clinical Trial For Osteoarthritis Of The Knee (PR Newswire)
16.10.17	MiMedx Announces Release Date for 2017 Third Quarter Results (PR Newswire)
13.10.17	MiMedx Adds New Materials To Its Website Exposing Misinformation Disseminated Through Short Seller Attacks (PR Newswire)
11.10.17	Multicenter Randomized Controlled VLU Clinical Study Published in the International Wound Journal Demonstrates Significantly Higher Healing Rates of MiMedx EpiFix® (PR Newswire)
11.10.17	CRY Opens Wallet, LLY's JUNIPER Flops, MDXG Catches Eyes, RNN Awaits DATA In Q4 (RTTNews)
10.10.17	MiMedx Adds New Materials To Its Website Exposing Misinformation Disseminated Through Short Seller Attacks (PR Newswire)
10.10.17	MiMedx Announces Third Quarter Revenues Of $84.6 Million Exceeds Guidance By More Than 5 Percent (PR Newswire)
10.10.17	CLVS Seeks New Use For Rubraca, TNDM Effects Reverse Stock Split, MDXG On Watch (RTTNews)
09.10.17	MiMedx Board of Directors Authorizes $10 Million Increase to the Company's Share Repurchase Program (PR Newswire)
06.10.17	MiMedx to Present at the Janney Osteoarthritis Pain Conference (PR Newswire)
04.10.17	Lifshitz & Miller LLP Announces Investigation of Foundation Medicine, Inc., Health Insurance Innovations, Inc., Juno Therapeutics, Inc., LendingClub Corporation, MiMedx Group, Inc., Ooma, Inc. (PR Newswire)
03.10.17	Dr. Gloria Matthews Joins MiMedx As Its Senior Vice President Of Research And Development (PR Newswire)
03.10.17	VICL Soars After-hours, DMTX Deems RARE Bid Superior, MDXG On Watch (RTTNews)
02.10.17	MiMedx Completes Divestiture Of Its Stability Biologics Subsidiary (PR Newswire)
29.09.17	MiMedx Publishes Document on its Website Exposing False and Misleading Information Distributed By Viceroy Research and Aurelius Value (PR Newswire)
22.09.17	Block & Leviton LLP Investigates MiMedx Group, Inc. (MDXG) Following Revelation Of SEC Investigation (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Lonza Grp	604.20	1.10 %	K V
ABB	49.33	0.61 %	K V
Logitech Intl	89.00	0.43 %	K V
Zurich Insur Gr	555.40	0.40 %	K V
Swiss Re	139.25	0.29 %	K V
Holcim	90.08	-0.77 %	K V
Novartis	95.27	-0.85 %	K V
Swisscom	505.00	-0.98 %	K V
Sonova Hldg	305.60	-3.29 %	K V
UBS Group	29.75	-6.42 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu MiMedx Group Inc

Aktien Top/Flop

Meistgelesene Nachrichten